An estimated 10 million U.S. adults microdosed psilocybin, LSD or MDMA in 2025, according to research published by the ...

LSD has shown promise for treating conditions like depression, but it might not do much for ADHD. © cybermagician via Shutterstock LSD can do a lot of things, but ...

Taking small, repeated doses of the psychedelic drug LSD doesn’t alleviate ADHD symptoms any more than a placebo. To test the drugs’ effects on ADHD more rigorously, Matthias Liechti at the University ...

Nearly 10 million American adults microdosed psychedelic substances such as psilocybin, LSD or MDMA in 2025, according to a ...

In this randomized study, microdosing LSD was not more effective than placebo in reducing ADHD symptoms in adults. Repeated doses of the low-dose LSD were safe in an outpatient setting.

Microdosing is gaining popularity with a new breed of health seekers. These self-experimenters take a very small amount of psilocybin mushrooms or lysergic acid diethylamide (LSD) to try to reduce ...

VANCOUVER, BC / ACCESSWIRE / September 5, 2023 / MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio"), is pleased to report it has made a major discovery from genetic ...

DENVER — In late 2023, Crystal Peterson was feeling desperate. The 44-year-old Cortez resident had long suffered from panic attacks that awoke her in the middle of the night. As the nights grew longer ...

BAN AND UNIVERSAL BACKGROUND CHECKS. WELL, IT’S A TOPIC THAT’S BEEN GAINING POPULARITY MICRODOSING WITH PSYCHEDELICS. NOW KOAT U-N-M HEALTH EXPERT DOCTOR ASH SPOKE WITH DARLENE MELENDEZ ABOUT THIS AND ...

Psychedelics have entered the mainstream in a big way: Investors have staked billions on potential medical treatments, scientific research has skyrocketed and public sentiment signals growing ...

VANCOUVER, British Columbia, May 10, 2023 (GLOBE NEWSWIRE) -- MindBio Therapeutics (CSE:MBIO), through its scientific collaborators, has published its first Peer Reviewed Paper in Biological ...

Microdosing is gaining popularity with a new breed of health seekers. These self-experimenters take a very small amount of psilocybin mushrooms or LSD to try to reduce anxiety, stress and depression.